IL6 and melanoma: We also found that inhibition of MAPK signaling pathway in human melanoma cells by genetic depletion of mutant BRAF or specific inhibitors reduced production of multiple immunosuppressive cytokines such as IL-6, IL-10, and VEGF, in most cases without affecting cell viability (Sumimoto et al., 2006).